Evidence map›Paper›PMID 22167743›Full record

ArticleJournal of lipid research2012

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice.

Mohamad Navab, Srinivasa T Reddy, G M Anantharamaiah, Greg Hough, Georgette M Buga, Jan Danciger, Alan M Fogelman

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Apolipoprotein mimetics in cancer.Seminars in cancer biology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mohamad NavabDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: mnavab@mednet.ucla.edu.
Srinivasa T ReddyDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
G M AnantharamaiahDepartment of Medicine, University of Alabama at Birmingham, AL.
Greg HoughDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Georgette M BugaDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Jan DancigerDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Alan M FogelmanDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
University of California, Los Angeles · USUniversity of Alabama at Birmingham · US

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
SYNTHETIC PEPTIDE STUDIES OF THE AMPHIPATHIC HELIXP01HL034343 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SEGREST, JERE P · 1985 to 2012
$18.8M
NHLBI NIH HHS HL-30568NHLBI NIH HHS HL-34343NHLBI NIH HHS P01 HL030568NHLBI NIH HHS P01 HL034343
6 · The paper itself

Abstract

To test the hypothesis that intestine is a major site of action for D-4F, LDLR(-/-) mice were fed a Western diet (WD) and administered the peptide subcutaneously (SQ) or orally. Plasma and liver D-4F levels were 298-fold and 96-fold higher, respectively, after SQ administration, whereas peptide levels in small intestine only varied by 1.66 ± 0.33-fold. Levels of metabolites of arachidonic and linoleic acids known to bind with high affinity to D-4F were significantly reduced in intestine, liver and hepatic bile to a similar degree whether administered SQ or orally. However, levels of 20-HETE, which is known to bind the peptide with low affinity, were unchanged. D-4F treatment reduced plasma serum amyloid A (SAA) and triglyceride levels (P < 0.03) and increased HDL-cholesterol levels (P < 0.04) similarly after SQ or oral administration. Plasma levels of metabolites of arachidonic and linoleic acids significantly correlated with SAA levels (P < 0.0001). Feeding 15-HETE in chow (without WD) significantly increased plasma SAA and triglyceride levels and decreased HDL-cholesterol and paraoxonase activity (P < 0.05), all of which were significantly ameliorated by SQ D-4F (P < 0.05). We conclude that D-4F administration reduces levels of free metabolites of arachidonic and linoleic acids in the small intestine and this is associated with decreased inflammation in LDL receptor deficient mice.

Indexed as

AnimalsApolipoprotein A-IArachidonic AcidBileFemaleInflammationIntestine, SmallLinoleic AcidsLiverMiceMice, KnockoutReceptors, LDLApolipoprotein A-IArachidonic AcidD-4F peptideLinoleic AcidsReceptors, LDL

Identifiers

PMID22167743
PMCPMC3276467
OpenAlexW2118829909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.